psilocybin psilocybin
Stories About

psilocybin

A study finds that psilocybin can desynchronize networks in the brain, potentially enhancing its plasticity. Sara Moser/Washington University School of Medicine in St. Louis hide caption

toggle caption
Sara Moser/Washington University School of Medicine in St. Louis

A prominent brain scientist took psilocybin as part of his own brain study

  • Download
  • <iframe src="https://www.npr.org/player/embed/g-s1-11501/nx-s1-d613551f-c1de-4725-8ed3-dba5b81e09b4" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Psilocybin mushroom grown in Littleton, Colo. Use of the psychoactive drug is growing in popularity in the U.S. Hyoung Chang/Denver Post/Getty Images hide caption

toggle caption
Hyoung Chang/Denver Post/Getty Images

Magic mushrooms drive interest in psychedelics

  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5021788/nx-s1-c7c6f9cf-76fb-43bf-a7e2-8bd05bc252a6" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Psilocybin mushrooms jarred and ready for distribution at Uptown Fungus lab in Springfield, Ore. Oregon has decriminalized the use of the psychedelic drug. Craig Mitchelldyer/AP hide caption

toggle caption
Craig Mitchelldyer/AP

As 'magic mushrooms' got more attention, drug busts of the psychedelic drug went up

  • Download
  • <iframe src="https://www.npr.org/player/embed/1229298615/1229405750" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dried Psilocybe mushrooms on a glass plate. James MacDonald/Bloomberg/Getty Images hide caption

toggle caption
James MacDonald/Bloomberg/Getty Images

As psychedelic-assisted therapy grows, so does interest from a new group: chaplains

  • Download
  • <iframe src="https://www.npr.org/player/embed/1201095225/1201383755" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A Washington, D.C., resident has an operation growing psilocybin mushrooms. Brain researchers are increasingly studying psychedelic compounds like psilocybin and LSD as potential treatments for anxiety, depression and other disorders. Jahi Chikwendiu/The Washington Post via Getty Images hide caption

toggle caption
Jahi Chikwendiu/The Washington Post via Getty Images

Psychedelic drugs may launch a new era in psychiatric treatment, brain scientists say

  • Download
  • <iframe src="https://www.npr.org/player/embed/1145306096/1145546384" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

LSD blotter tabs sit on top of a US quarter coin. A drug based off of psychedelic LSD appears to relieve depression and anxiety in mice, but without the hallucinogenic side effects. PAUL J. RICHARDS/AFP via Getty Images hide caption

toggle caption
PAUL J. RICHARDS/AFP via Getty Images

Root extracts from the African shrub iboga have long been used in traditional healing rituals and more recently as an experimental treatment for depression and to reduce drug cravings in addiction. Scientists now are working on a version of the extract that doesn't cause heart attacks or hallucinations as side effects. Steeve Jordan/AFP via Getty Images hide caption

toggle caption
Steeve Jordan/AFP via Getty Images

Progress Toward A Safer Psychedelic Drug To Treat Depression And Addiction

  • Download
  • <iframe src="https://www.npr.org/player/embed/944572325/944739800" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The hallucinogenic chemical psilocybin produced in some mushrooms helped people with major depression in a study that also included supportive psychotherapy. Jahi Chikwendiu/The Washington Post via Getty Images hide caption

toggle caption
Jahi Chikwendiu/The Washington Post via Getty Images

Rigorous Study Backs A Psychedelic Treatment For Major Depression

  • Download
  • <iframe src="https://www.npr.org/player/embed/931377532/931436050" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An old problem has a potential new solution: Using psilocybin has helped patients quit smoking in a clinical trial. Xakhr Chay Tha Man / EyeEm/Getty Images/EyeEm hide caption

toggle caption
Xakhr Chay Tha Man / EyeEm/Getty Images/EyeEm

The director of the Denver campaign told NPR that the results from the vote shows that society's perception of psychedelics has changed. Photofusion/UIG via Getty Images hide caption

toggle caption
Photofusion/UIG via Getty Images

A growing body of research suggests psychedelic mushrooms may have therapeutic benefits for certain conditions. Now a movement seeks to decriminalize them. farmer images/Getty Images hide caption

toggle caption
farmer images/Getty Images